Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

Figure 6

CT-322 causes tumor destruction. A) Sections of MiaPaCa-2 tumors were fixed in formalin and paraffin embedded. H&E staining revealed homogenous histology in tumors from the control treated animals. In contrast tumors from CT-322 treated animals showed large areas of tumor destruction (*). Representative images from each group are shown. B) Formalin fixed paraffin embedded MiaPaCa-2 tumor sections from animals treated with control or CT-322 were stained for TUNEL activity. The mean (+/- SEM) % of pixels above threshold is displayed. Treatment with CT-322 increased the number of TUNEL-positive apoptotic cells per tumor section (control 4.3 ± 2.03, CT-322 30.6 ± 6.9). Images were analyzed using Nikon Elements imaging software (2 tumors per group, 10 fields per tumor were analyzed, p < .001). Two representative pictures from each group are shown.

Back to article page
\